MedTech News
.................... by Andrew Celentano
Cancer cells release antioxidants to prevent immune cells from destroying them
Molecules called reactive oxygen species, which include so-called “free radicals,” have long been viewed as damaging byproducts of our body’s metabolism—a reason antioxidant supplements have been considered a potential way to reduce cancer risk.
Hamamatsu Receives FDA 510(k) Clearance for NanoZoomer S20MD and S540MD Slide scanner systems
New FDA clearances expand Hamamatsu’s FDA-cleared NanoZoomer portfolio with compact benchtop and high-throughput digital pathology solutions.
Bayesian Health’s FDA-Cleared Continuous AI Sepsis Monitor
Beginning October 1, 2026, hospitals using Bayesian’s continuous sepsis monitor can receive additional Medicare reimbursement for eligible inpatient cases, the first reimbursement pathway of its kind for presuspicion sepsis monitoring.
FDA grants 510(k) clearance to Medibyt’s CPETWise solution
CPETWise automates and standardises CPET workflow, transforming complex physiological data into streamlined processes.
Vara nets first CE mark for autonomous AI breast cancer screening tool
The autonomous triage system’s European market authorisation comes as AI becomes increasingly embedded into the cancer screening paradigm.
Stryker introduces FDA-cleared surgical application for Apple Vision Pro
Stryker (NYSE: SYK) has announced the first clinical use of SportsSuite Vision using the mixed-reality Apple Vision Pro.
Small spaces and stiffness may help cancer cells escape and spread
A new biomaterial developed by researchers from The University of Western Australia is providing fresh insights into the way cancer cells escape from tumors and spread through the body.
New class of KRAS inhibitors shows promise in shrinking NF1 nerve tumors
A scientist at Cincinnati Children’s who has hunted for decades for ways to shrink the painful and disfiguring nerve tumors caused by neurofibromatosis type 1 (NF1) has made a new breakthrough in the quest.